Latest filing published 08 Feb 2019 for ALDER BIOPHARMACEUTICALS INC, €3,997.
Filing timeline
BuySaleInsider track record
John A. Latham: trading record in brief
John A. Latham appears in our data through filings on Alder Biopharmaceuticals Inc shares, published by SEC (Form 4). The record holds 82 filings, for trades running from 26 January 2015 to 30 November 2018.
Sales make up the whole of the open-market record (43 sales, €8.5M). Other entries cover 3 share grants and 36 option exercises.
The latest filing, published on 8 February 2019, reports a share grant of €3,997 in Alder Biopharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John A. Latham
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 487 shares@ US$9.350.1% of flowCommon StockSEC:0001209191-19-008581:0
- 6,821 shares@ US$6.771.3% of flowCommon StockSEC:0001209191-18-057261:0
- 18,181 shares@ US$10.005.3% of flowCommon StockSEC:0001209191-18-057261:1
- 23,683 shares@ US$13.409.2% of flowCommon StockSEC:0001209191-18-057261:2
- 1,319 shares@ US$13.780.5% of flowCommon StockSEC:0001209191-18-057261:3
- 18,185 shares@ US$3.471.8% of flowCommon StockSEC:0001209191-18-054084:0
- 6,814 shares@ US$6.771.3% of flowCommon StockSEC:0001209191-18-054084:1
- 18,445 shares@ US$15.257.9% of flowCommon StockSEC:0001209191-18-054084:2
- 6,554 shares@ US$15.973.0% of flowCommon StockSEC:0001209191-18-054084:3
- 24,999 shares@ US$3.472.4% of flowCommon StockSEC:0001209191-18-049870:0
- 24,999 shares@ US$17.9912.7% of flowCommon StockSEC:0001209191-18-049870:1
- 24,999 shares@ US$3.472.4% of flowCommon StockSEC:0001209191-18-045039:0
- 24,999 shares@ US$19.5513.7% of flowCommon StockSEC:0001209191-18-045039:1
- 24,999 shares@ US$3.472.4% of flowCommon StockSEC:0001209191-18-041228:0
- 24,999 shares@ US$15.4810.8% of flowCommon StockSEC:0001209191-18-041228:1
- 4,799 shares@ US$18.251.2% of flowCommon StockSEC:0001209191-18-035876:3
- 22,727 shares@ US$4.461.4% of flowCommon StockSEC:0001209191-18-035876:0
- 2,272 shares@ US$3.470.1% of flowCommon StockSEC:0001209191-18-035876:1
- 20,200 shares@ US$17.765.1% of flowCommon StockSEC:0001209191-18-035876:2
- 333 shares@ US$13.090.1% of flowCommon StockSEC:0001209191-17-066206:0
- 472 shares@ US$9.350.1% of flowCommon StockSEC:0001209191-17-066206:1
- 3,636 shares@ US$1.650.1% of flowCommon StockSEC:0001209191-16-153488:0
- 3,136 shares@ US$22.641.1% of flowCommon StockSEC:0001209191-16-153488:1
- 500 shares@ US$23.620.2% of flowCommon StockSEC:0001209191-16-153488:2
- 10,000 shares@ US$1.650.2% of flowCommon StockSEC:0001209191-16-149937:0
25 of 81 declarations